Method development for quantification of the environmental neurotoxin annonacin in Rat plasma by UPLC-MS/MS and application to a pharmacokinetic study.

[1]  R. Levine,et al.  Determination of Neurotoxic Acetogenins in Pawpaw (Asimina triloba) Fruit by LC-HRMS. , 2015, Journal of agricultural and food chemistry.

[2]  David Touboul,et al.  Identification of the environmental neurotoxins annonaceous acetogenins in an Annona cherimolia Mill. Alcoholic Beverage Using HPLC-ESI-LTQ-Orbitrap. , 2014, Journal of agricultural and food chemistry.

[3]  W. Oertel,et al.  Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice , 2014, Experimental Neurology.

[4]  D. Touboul,et al.  Comprehensive characterization of Annonaceous acetogenins within a complex extract by HPLC-ESI-LTQ-Orbitrap® using post-column lithium infusion. , 2012, Journal of mass spectrometry : JMS.

[5]  P. Singh,et al.  Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. , 2012, Cancer letters.

[6]  Xiang Li,et al.  Determination of bullatacin in rat plasma by liquid chromatography-mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  Chun-yan Zhu,et al.  In Situ Absorption in Rat Intestinal Tract of Solid Dispersion of Annonaceous Acetogenins , 2012, Gastroenterology research and practice.

[8]  I. Litvan,et al.  Annonacin in Asimina triloba fruit: implication for neurotoxicity. , 2012, Neurotoxicology.

[9]  V. Guérineau,et al.  Structural study of acetogenins by tandem mass spectrometry under high and low collision energy. , 2010, Rapid communications in mass spectrometry : RCM.

[10]  A. Schapira.  Complex I: Inhibitors, inhibition and neurodegeneration , 2010, Experimental Neurology.

[11]  C. Liaw,et al.  Historic Perspectives on Annonaceous Acetogenins from the Chemical Bench to Preclinical Trials , 2010, Planta medica.

[12]  V. Guérineau,et al.  MALDI-TOF MS Profiling of Annonaceous Acetogenins in Annona muricata Products for Human Consumption , 2009, Molecules.

[13]  M. Ruberg,et al.  Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies , 2009, Experimental Neurology.

[14]  J. McLaughlin.  Paw paw and cancer: annonaceous acetogenins from discovery to commercial products. , 2008, Journal of natural products.

[15]  M. Ruberg,et al.  Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe , 2005, Movement disorders : official journal of the Movement Disorder Society.

[16]  D. Caparros-Lefebvre,et al.  Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses. , 2005, Environmental toxicology and pharmacology.

[17]  A. Bermejo,et al.  Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action. , 2005, Natural product reports.

[18]  Jean Féger,et al.  Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe , 2003, Journal of neurochemistry.